Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA – Get Free Report)’s stock price passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.17 and traded as high as $0.22. Sonoma Pharmaceuticals shares last traded at $0.21, with a volume of 2,093,695 shares changing hands.
Sonoma Pharmaceuticals Price Performance
The company has a market capitalization of $4.03 million, a price-to-earnings ratio of -0.29 and a beta of 1.37. The stock has a fifty day simple moving average of $0.18 and a 200-day simple moving average of $0.17.
Sonoma Pharmaceuticals Company Profile
Sonoma Pharmaceuticals, Inc, develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, Asia, and internationally. The company offers Regenacyn, a prescription scar gel; Pediacyn, a pediatric dermatology and wound care product for over-the-counter (OTC) use; Epicyn, an Antimicrobial Facial Cleanser; Levicyn, an HOCl based prescription and OTC product to use and relieve skin irritations, lacerations, abrasions, and burns; Celacyn, a scar management gel; and SebuDerm to manage and relieve the burning, itching, erythema, scaling, and pain associated with seborrhea and seborrheic dermatitis.
Read More
- Five stocks we like better than Sonoma Pharmaceuticals
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- EV Stocks and How to Profit from Them
- MarketBeat Week in Review – 6/24 – 6/28
- 3 Ways To Invest In Coffee, Other Than Drinking It
- General Mills Stock Drops After Revenue Miss in Fiscal Q4 2024
Receive News & Ratings for Sonoma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonoma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.